Search results

A study into why some people are more resistant than others to diseases such as tuberculosis and leprosy has identified a new genetic variant which affects susceptibility to…

A new suite of malaria maps has revealed the current global pattern of the disease in unprecedented detail, allowing researchers to see how malaria has changed over several…

How should the global community prioritise the distribution of Covid-19 vaccines to give us the best chance of ending the pandemic and saving lives? Could booster…

After many global conversations about lessons we can learn from the Covid-19 crisis, the G7 summit in Germany showed increasing commitment to facing threats of disease…

The licensing of the first Ebola vaccine is a great achievement for the global healthcare community. What made it possible, and what lessons can we use to prevent and control…

A study published today in the journal ‘Science’ shows how our bodies try to minimise potential ‘collateral damage’ caused by our immune system when fighting infection. The…

One in ten women (9.8%) and roughly one in seventy men (1.4%), when asked “Has anyone actually made you have sex with them, against your will?”, said yes, according to new…

Exposure to worm infections in the womb may protect a newborn infant from developing eczema, a study funded by the Wellcome Trust suggests. A large trial in Uganda showed…

Critics warned against the UK policy of leaving a longer gap between doses of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines. Now we have more data, what…

A vaccine for Covid-19 which uses cutting-edge RNA technology has entered phase 1 clinical trials. If successful, it could revolutionise the future of vaccine development.

Research from Malawi, Birmingham and Liverpool has renewed hope that an effective vaccine could be developed against nontyphoidal strains of Salmonella.

A YouGov poll, commissioned by Wellcome, reveals that 9 in 10 people (90%) in the UK say COVID-19 treatments and vaccines should first be provided for those who need them…

Ensuring the people who most need access to vaccines and effective treatments against Covid-19, wherever they are in the world, is supported by almost 9 in 10 German adults.

One in three French people think vaccines are unsafe, but across the country vaccine coverage is rising. Alex Whiting looks at how France is fighting back against vaccine…

The Wellcome Trust announced today that its AAA (stable) credit rating has been reaffirmed by Standard & Poor’s. The Trust continues to be rated Aaa (stable) by Moody’s…

Interim results from the Guinean phase III trial of the Ebola vaccine known as VSV-EBOV, co-funded by the Wellcome Trust, indicate that it is highly effective against the…

US public overwhelmingly support equitable global access to COVID-19 vaccines and treatments.

A clinical trial of a vaccine against a major cause of pneumonia and meningitis has shown that it can prevent three out of four cases of re-infection in HIV-infected adults…

The Government has thrown its support behind a unique £500 milion medical research partnership that will bring together the country's best scientists to bolster the battle…